Skip to main content
SpringerLink
Log in

Alpelisib/trastuzumab

Drug resistance and hyperglycaemia: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Sheth H, et al. Excellent response with alpelisib and bicalutamide for advanced salivary duct carcinoma with PIK3CA mutation and high androgen receptor expression-A case report. JCO Precision Oncology 5: 744-750, 2021. Available from: URL: https://ascopubs.org/doi/pdf/10.1200/PO.20.00436

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alpelisib/trastuzumab. Reactions Weekly 1889, 24 (2022). https://doi.org/10.1007/s40278-022-08703-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-08703-5

Search

Navigation